---
title: "Lake Street Remains a Buy on Opera (OPRA)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284402448.md"
description: "Lake Street analyst Jacob Stephan has maintained a Buy rating on Opera (OPRA) with a price target of $26.00. The analyst has an average return of 23.4% and a 55.61% success rate on his recommendations. The overall analyst consensus for Opera is a Strong Buy, with an average price target of $27.67."
datetime: "2026-04-28T13:58:25.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284402448.md)
  - [en](https://longbridge.com/en/news/284402448.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284402448.md)
---

# Lake Street Remains a Buy on Opera (OPRA)

Lake Street analyst Jacob Stephan maintained a Buy rating on Opera today and set a price target of $26.00.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Stephan covers the Technology sector, focusing on stocks such as Research Solutions, Alkami Technology, and Dave. According to TipRanks, Stephan has an average return of 23.4% and a 55.61% success rate on recommended stocks.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Opera with a $27.67 average price target.

### Related Stocks

- [OPRA.US](https://longbridge.com/en/quote/OPRA.US.md)
- [IGV.US](https://longbridge.com/en/quote/IGV.US.md)
- [XSW.US](https://longbridge.com/en/quote/XSW.US.md)
- [RSSS.US](https://longbridge.com/en/quote/RSSS.US.md)
- [ALKT.US](https://longbridge.com/en/quote/ALKT.US.md)
- [DAVE.US](https://longbridge.com/en/quote/DAVE.US.md)
- [DAVEW.US](https://longbridge.com/en/quote/DAVEW.US.md)

## Related News & Research

- [Nebius Group Analysts Increase Their Forecasts Following Q1 Earnings](https://longbridge.com/en/news/286435619.md)
- [Workday (WDAY) to Release Earnings on Thursday](https://longbridge.com/en/news/286368349.md)
- [Walmart Stock: Here’s Why Analysts Are Raising Price Targets Before Q1 Earnings.](https://longbridge.com/en/news/286950969.md)
- [Lake Street Reaffirms Their Buy Rating on Pelthos Therapeutics (PTHS)](https://longbridge.com/en/news/286569936.md)
- [Q2 EPS Forecast for Avalo Therapeutics Boosted by Analyst](https://longbridge.com/en/news/286903837.md)